AI-assisted international press reviewPress review

The European Commission Validates New Genomic Techniques

The EU has adopted a framework distinguishing two categories of plants derived from new genomic techniques (NGTs); category 1 plants, comparable to conventional varieties, are exempt from GMO legislation after verification, while category 2 plants remain subject to risk assessment, traceability, and labeling. NGTs enable precise and rapid modifications to develop plant varieties that are more resilient to climate, pests, and resource-efficient, promoting sustainable agriculture and supporting the competitiveness of the European agricultural sector.

SEPEHR ACHARD, Source: Igronews, published under the title "EU Commission Welcomes Political Agreement on New Genomic Te..." - 5 December 2025

CPB Contractors Wins Contract for New Perth Runway

CPB Contractors, a subsidiary of CIMIC Group, has secured the contract to construct a new 3 km runway at Perth Airport as part of a $5 billion transformation. This ambitious project, in partnership with BMD, aims to enhance passenger capacity and operational efficiency while prioritizing local employment, training, and sustainable construction methods. The works include demolitions, earthworks, and security systems, marking a significant step for the economy of Western Australia.

Source: Hochtief, published under the title "CIMIC’s CPB Contractors awarded Perth Airport enabling and l..." - 5 December 2025

CPB Contractors Wins Contract for New Perth Airport Runway

CPB Contractors, a subsidiary of CIMIC Group, has secured the contract to construct a new 3 km runway and taxiways at Perth Airport as part of a $5 billion ambitious project. This key project, in partnership with BMD, aims to enhance passenger capacity and operational efficiency while prioritizing local employment, skills training, and sustainable practices. With recognized expertise in airport infrastructure, CPB is committed to innovative, safe, and environmentally friendly construction, marking a decisive step for the economy of Western Australia. The works include demolitions, extensive earthworks, and advanced drainage systems for a smoother and greener airport.

Source: Cimic, published under the title "CIMIC's CPB Contractors awarded Perth Airport enabling and l..." - 5 December 2025

Building a Legacy with New Zealand's Infrastructure Giant

Jason Tutty, a true Dunedin local and 25-year veteran in construction, leads the colossal Dunedin Hospital project, one of New Zealand's most ambitious undertakings. Beyond bricks and mortar, he aims to transform the region by providing a world-class health facility for the South, boosting the local economy, creating jobs, and training youth. His passionate commitment promises a sustainable legacy, strengthening community partnerships and inspiring future generations in the industry. Discover how this project is changing lives!

Source: Cimic, published under the title "Building a legacy on New Zealand's largest infrastructure pr..." - 5 December 2025

UGL and Skillset: A Model Partnership for Indigenous Youth Employment

UGL and Skillset: An Innovative Partnership for Indigenous Youth Employment in Regional Australia. Since 2020, they have placed over 15 students in local businesses in Dubbo, leading to remarkable successes such as full-time jobs, award-winning internships, and annual programs. Supported by UGL's training expertise, this collaborative model enhances local skill development and inspires inclusive strategies in the Central West Orana renewable energy zone. Recognized as Host Employer of the Year 2025 by Skillset, UGL is paving the way for a fair professional future.

Source: Cimic - 5 December 2025

Mechanization & Robotics

DJI Revolutionizes Aerial Delivery with the FC100 Drone

The new DJI FC100 delivery drone, featuring enhanced payload capacity and an advanced safety system, is designed to meet the growing demands of emergency and logistics sectors. Equipped with fast-charging technology and a dedicated app for operation management, the FC100 promises to optimize deliveries in challenging environments while ensuring operational safety.

Source: Dji, published under the title "DJI Redefines Aerial Delivery with DJI FlyCart 100" - 4 December 2025

Pepsi Zero Sugar Outperforms Coke and Expands Its Iconic Challenge in 2026

Pepsi Zero Sugar triumphs in America: 100% of victories in The Pepsi Challenge, including in Atlanta, with a consumer preference of over 60%! Over one million samples distributed at major cultural events, a 30.8% sales growth in 2025, and a skyrocketing market share reaching an additional million households. The challenge continues in 2026 to confirm its supremacy.

Source: Pepsico, published under the title "After proving PEPSI® Zero Sugar out-tastes Coke Zero Sugar, ..." - 4 December 2025

Mars Invests $20 Million in Sustainable Rice Amid Climate Challenges

Mars is investing $20 million by 2030 to transform rice cultivation in the face of climate change. By supporting smart agricultural practices, the initiative aims to reduce greenhouse gas emissions, water usage, and secure farmers' incomes in India, Thailand, and beyond, while safeguarding overall yields. A crucial step for a sustainable future of rice, a staple for billions.

Source: Mars Incorporated, published under the title "Mars investing $20 million in sustainable rice sourcing" - 4 December 2025

Mars Drives Climate Agriculture in Europe for Healthier Soils

"Crops are reborn and profitability returns, even in tough years": Mars supports 300 European farmers across 60,900 hectares for smart agricultural practices. On World Soil Day, the company urges policymakers to promote public-private partnerships and results-oriented policies to scale these sustainable solutions.

Source: Mars Incorporated, published under the title "Mars champions Europe’s farmers & calls to scale climate-sma..." - 4 December 2025

Abbott Launches Ensure Shakes to Boost Muscle Health!

Discover how Abbott and Matt Ryan are enhancing muscle health after 40! With the new Ensure Max Protein shakes, combat muscle loss: the 42g option for active adults, rich in protein, vitamins, and electrolytes to build muscle, and the 2-in-1 for seniors, with 30g of protein and CaHMB to slow degradation. Studies also show that protein helps stabilize glucose, promoting lasting vitality. Take charge for a fit life!

Source: Abbott, published under the title "Muscles, The New Flex: Abbott Launches Two New Ensure® Max P..." - 3 December 2025

Bayer Launches Promising Study on Alport Syndrome!

Bayer initiates an innovative clinical trial for BAY 3401016, a monoclonal antibody aimed at blocking Sema3A and slowing kidney damage in Alport syndrome, a rare genetic disease. In collaboration with Evotec and patient associations, this program, which has received FDA Fast Track and Orphan Drug designations, enhances the hope for an effective treatment.

Source: Bayer, published under the title "MediaBayer starts Phase IIa study for treatment of patients ..." - 3 December 2025

AstraZeneca Accelerates in Hematology with Record at ASH 2025

AstraZeneca is revolutionizing the management of blood cancers: Promising initial data for surovatamig, a T-cell engager, and AZD0120, a CAR T therapy, in follicular lymphoma and multiple myeloma. Results reinforce the benefits of Calquence in patients with mantle cell lymphoma and chronic lymphocytic leukemia, while Ultomiris confirms its potential in paroxysmal nocturnal hemoglobinuria and in children with post-transplant microangiopathic thrombosis. Advances that redefine the future of hematology.

Source: Astrazeneca, published under the title "AstraZeneca advances haematology and cell therapy ambition w..." - 3 December 2025

Sanofi Acquires Vicebio to Enhance Its Respiratory Vaccines

Sanofi strengthens its leadership in respiratory vaccines: the acquisition of Vicebio brings innovative technology, the 'Molecular Clamp', for a combined vaccine candidate against RSV and HMPV, providing a non-mRNA alternative and expanding options for public health. This strategic move complements Sanofi's pipeline, promoting advancements in the fight against respiratory viruses.

Source: Sanofi, published under the title "Press Release: Sanofi completes acquisition of Vicebio" - 3 December 2025

Naomi Watts and Johnson & Johnson: Eye Exams, Key to Well-Being After 40

Alarming revelation: A new survey shows that Americans are neglecting their eye health, despite its major impact on confidence, independence, and early detection of diseases like diabetes or heart disorders. With Naomi Watts and Johnson & Johnson, it's time to prioritize regular check-ups for healthy aging!

Source: J&j, published under the title "Johnson & Johnson Teams Up with Naomi Watts to Reveal Why an..." - 3 December 2025

SPARK Exceeds Its Training Goals Ahead of Schedule!

CPB Contractors triumphs with the SPARK consortium on the North East Link: 100% of the Major Projects Skills Guarantee (MPSG) target achieved several years ahead of schedule! Over 1.7 million hours dedicated to apprentices, trainees, and cadets, training 689 trainees, 110 apprentices, and 81 cadets, with 52 recognized qualifications and an innovative underground construction program. An exemplary commitment to local jobs and skills enhancement in Victoria.

Source: Cimic, published under the title "Building skills and futures at SPARK" - 3 December 2025

ACS Expands Partnership with Vulcan for European Lithium Giant

ACS Group strengthens its partnership with Vulcan Energy, a pioneer in sustainable lithium in Europe, to orchestrate the green production of 24,000 tons of lithium per year through the Lionheart project. Together with Sedgman and HOCHTIEF, experts in critical minerals, they manage the engineering, construction, and operation of the plants while generating renewable energy. This €169 million investment marks a decisive step towards Europe's energy independence, powering 500,000 electric vehicles without fossil emissions. An innovative collaboration for a sustainable future!

Source: Grupoacs, published under the title "ACS Group expands strategic partnership with Vulcan Energy t..." - 3 December 2025

ACS and Vulcan Accelerate Sustainable Lithium in Europe

ACS Group strengthens its partnership with Vulcan Energy, a pioneer in sustainable lithium and renewable energies, by taking a key role in the development of production infrastructure. With Sedgman and HOCHTIEF, the Lionheart project – valued at 734 million euros – will see the construction of plants to extract and process lithium from geothermal sources, producing enough for 500,000 electric vehicles annually, without fossil emissions. This 169 million euro investment from HOCHTIEF underscores the commitment to European independence in critical materials and the energy transition. A major step towards a sustainable and innovative future in Europe!

Source: Cimic - 3 December 2025

HOCHTIEF and Vulcan: The European Lithium Giant on the Move

HOCHTIEF and Sedgman accelerate Vulcan Energy's Lionheart project: sustainable lithium production for 500,000 electric vehicles per year, enabled by zero-carbon geothermal extraction. A €169 million investment, strategic project status under the EU's Critical Raw Materials Act, and a partnership for European energy independence. A significant step towards a clean and innovative future.

Source: Hochtief, published under the title "HOCHTIEF Group expands strategic partnership with Vulcan Ene..." - 3 December 2025

Bayer Innovates in Pediatric MRI with Low-Dose Agent

Bayer reveals initial results from the QUANTI Pediatric study for its MRI contrast agent gadoquatrane, an innovative low-dose product that reduces gadolinium exposure by 60% in children from birth to 18 years. This research confirms promising safety and efficacy, supporting market authorization requests with global health authorities for safer medical imaging tailored for younger patients. These advancements could transform practices in pediatric radiology.

Source: Bayer, published under the title "Data from Pediatric Study for Bayer's Investigational MRI Co..." - 2 December 2025

Nipocalimab: First FcRn Antibody Approved for Generalized Myasthenia Gravis

The European Medicines Agency has approved nipocalimab, an innovative monoclonal antibody, for the treatment of generalized myasthenia gravis in adults and adolescents. This therapeutic advancement aims to reduce IgG levels, which are responsible for the debilitating symptoms of the disease, while preserving immune functions. Clinical study results show significant symptom improvement, providing a new option for patients, estimated to number between 56,000 and 123,000 in Europe.

Source: J&j - 2 December 2025